Guest Blogs - Page 3 of 53 - Express Pharma

Six business lessons from Cipla’s nine-decade journey

USFDA and EUDRA dashboards offer lessons for strengthening India’s regulatory transparency

From fintech to aesthetic injectables: Lessons in navigating regulatory formalisation

Why ingredient transparency matters more than ever in cosmeceuticals

Beyond ozempic: GLP-1s and the next wave of anti-obesity drugs

India patent office can bridge the gap with global patent search platforms

How India reimagined healthcare in 12 years—and what comes next

Pharmacy beyond pills: Why India needs better drug awareness and pharmacy practice

An emerging disruption in drug traceability for India and beyond

China+1 moment for pharma: How India can convert opportunity into long-term contracts